Filter News
Area of Research
- (-) National Security (4)
- (-) Neutron Science (10)
- Advanced Manufacturing (4)
- Biology and Environment (33)
- Clean Energy (38)
- Climate and Environmental Systems (1)
- Computational Biology (1)
- Computational Engineering (2)
- Fusion and Fission (4)
- Fusion Energy (7)
- Isotopes (3)
- Materials (23)
- Materials for Computing (5)
- Mathematics (1)
- Nuclear Science and Technology (10)
- Nuclear Systems Modeling, Simulation and Validation (1)
- Supercomputing (20)
News Type
News Topics
- (-) Advanced Reactors (1)
- (-) Biomedical (7)
- (-) Climate Change (1)
- (-) Composites (1)
- (-) Coronavirus (6)
- 3-D Printing/Advanced Manufacturing (4)
- Artificial Intelligence (8)
- Big Data (3)
- Bioenergy (5)
- Biology (5)
- Biotechnology (1)
- Chemical Sciences (3)
- Computer Science (15)
- Cybersecurity (10)
- Decarbonization (1)
- Energy Storage (6)
- Environment (6)
- Exascale Computing (1)
- Frontier (2)
- Fusion (2)
- Grid (3)
- High-Performance Computing (2)
- Machine Learning (4)
- Materials (10)
- Materials Science (16)
- Microscopy (2)
- Nanotechnology (7)
- National Security (11)
- Neutron Science (63)
- Nuclear Energy (3)
- Partnerships (4)
- Physics (9)
- Quantum Science (5)
- Security (7)
- Space Exploration (2)
- Summit (5)
- Sustainable Energy (3)
- Transportation (5)
Media Contacts
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.
A partnership of ORNL, the Tennessee Department of Economic and Community Development, the Community Reuse Organization of East Tennessee and TVA that aims to attract nuclear energy-related firms to Oak Ridge has been recognized with a state and local economic development award from the Federal Laboratory Consortium.
ORNL scientists will present new technologies available for licensing during the annual Technology Innovation Showcase. The event is 9 a.m. to 3 p.m. Thursday, June 16, at the Manufacturing Demonstration Facility at ORNL’s Hardin Valley campus.
Scientists have found new, unexpected behaviors when SARS-CoV-2 – the virus that causes COVID-19 – encounters drugs known as inhibitors, which bind to certain components of the virus and block its ability to reproduce.
Six ORNL scientists have been elected as fellows to the American Association for the Advancement of Science, or AAAS.
Experiments led by researchers at ORNL have determined that several hepatitis C drugs can inhibit the SARS-CoV-2 main protease, a crucial protein enzyme that enables the novel coronavirus to reproduce.
To better understand how the novel coronavirus behaves and how it can be stopped, scientists have completed a three-dimensional map that reveals the location of every atom in an enzyme molecule critical to SARS-CoV-2 reproduction.
A team of researchers has performed the first room-temperature X-ray measurements on the SARS-CoV-2 main protease — the enzyme that enables the virus to reproduce.
Oak Ridge National Laboratory’s high-resolution population distribution database, LandScan USA, became permanently available to researchers in time to aid the response to the novel coronavirus pandemic.
OAK RIDGE, Tenn., March 20, 2019—Direct observations of the structure and catalytic mechanism of a prototypical kinase enzyme—protein kinase A or PKA—will provide researchers and drug developers with significantly enhanced abilities to understand and treat fatal diseases and neurological disorders such as cancer, diabetes, and cystic fibrosis.